Table 6.
Total (N = 11,529) |
Northern Europe (N = 3, 723) |
Southern Europe (N = 4, 679) |
North America (N = 904) |
Middle East (N = 485) |
Asia (N = 1, 738) |
P value | |
---|---|---|---|---|---|---|---|
SBP (mmHg) | |||||||
<120 | 2.9 (0.044) | 3.0 (0.088) | 3.0 (0.076) | 2.5 (0.109) | 2.8 (0.231) | 2.8 (0.093) | 0.0003 |
120–139 | 3.0 (0.048) | 3.1 (0.035) | 3.0 (0.028) | 2.4 (0.054) | 2.9 (0.121) | 2.9 (0.042) | <0.0001 |
140–159 | 3.2 (0.015) | 3.2 (0.025) | 3.2 (0.024) | 2.6 (0.053) | 3.4 (0.075) | 3.0 (0.038) | <0.0001 |
160–179 | 3.3 (0.020) | 3.3 (0.033) | 3.3 (0.032) | 2.7 (0.081) | 3.5 (0.080) | 3.3 (0.057) | <0.0001 |
≥180 | 3.4 (0.034) | 3.4 (0.055) | 3.5 (0.058) | 3.0 (0.153) | 3.9 (0.131) | 3.5 (0.096) | <0.0001 |
P value | <0.0001 | <0.0001 | <0.0001 | <0.0001 | 0.0005 | <0.0001 | |
DBP (mmHg) | |||||||
<90 | 3.0 (0.013) | 3.1 (0.022) | 3.1 (0.021) | 2.4 (0.037) | 3.0 (0.081) | 2.9 (0.031) | <0.0001 |
90–99 | 3.3 (0.016) | 3.3 (0.028) | 3.3 (0.027) | 2.8 (0.074) | 3.4 (0.073) | 3.1 (0.045) | <0.0001 |
100–109 | 3.4 (0.026) | 3.4 (0.047) | 3.4 (0.041) | 2.9 (0.141) | 3.9 (0.098) | 3.4 (0.069) | <0.0001 |
≥110 | 3.5 (0.049) | 3.5 (0.086) | 3.6 (0.080) | 3.9 (0.311) | 3.5 (0.169) | 3.6 (0.151) | 0.5736 |
P value | <0.0001 | <0.0001 | <0.0001 | <0.0001 | <0.0001 | <0.0001 | |
RR (mmHg) | |||||||
uncontrolled* | 3.4 (0.014) | 3.3 (0.019) | 3.3 (0.018) | 2.7 (0.042) | 3.5 (0.050) | 3.1 (0.029) | <0.0001 |
controlled** | 3.0 (0.012) | 3.0 (0.034) | 3.0 (0.027) | 2.4 (0.050) | 2.9 (0.115) | 2.9 (0.040) | <0.0001 |
P value | <0.0001 | <0.0001 | <0.0001 | <0.0001 | <0.0001 | <0.0001 |
*SBP/DBP ≥140/90 in non-diabetic and ≥130/80 in diabetic patients, **<140/90 in non-diabetic and <130/80 in diabetic patients.